What is ZANTAC Lawsuit? Types of Cancer Caused by Zantac.
Zantac: What is it?
Ranitidine (Zantac) is a member of the H2RA drug subclass. These medicines lessen the stomach’s production of acid. Prior to now, these ailments were treated with Zantac by medical professionals:
- Excessive Bodily Secretions
- Gastroesophageal Reflux Disease (GERD)
- Duodenal Ulcers, which affect the first part of the small intestine
- Stomach Ulcers
Can Zantac lead to cancer?
On the American market, ranitidine-based Zantac is no longer offered. The information about adverse effects on this page is solely for Zantac made with ranitidine, not Sanofi’s new Zantac 360 created with famotidine, which is unaffected by the market removal.
French researchers who published their findings in the US journal found that the rate of side effects associated with Zantac in clinical trials was very comparable to that of patients who took a placebo, or an inert drug.
Zantac and it’s roots to Cancer
A possible link between ranitidine and its capacity to create NDMA is the source of worries over Zantac’s association to cancer. Some research from the 1980s suggested a connection between the drug and the production of NDMA.
The potential connection between ranitidine, the chemical name for Zantac, and the carcinogenic substance NDMA was discovered by two Italian medical researchers in 1983. Zantac includes “DMA” (dimethylamine), which interacts with the “N” in commonly consumed foods to form nitrosamines, nitrites, and nitrates. Even though Zantac is always given with food, some early researchers actually cautioned against doing so.
How Likely Are You to Develop Cancer?
Scientists haven’t established an exact risk level because there is now only weak evidence that the NDMA in ranitidine contributes to cancer.
Researchers at Memorial Sloan Kettering Cancer Center have reportedly found an elevated risk in the possibilities of developing certain tumours.
What Gives Rise to Class Action Lawsuit against Zantac?
After manufacturers issued ranitidine and Zantac recalls due to the potential risk of cancer, people who took ranitidine-containing Zantac and acquired cancer filed ranitidine lawsuit. Ranitidine, the main ingredient in Zantac, was determined by the FDA to contain N-Nitrosodimethylamine (NDMA), a possible human carcinogen.
The FDA informed all manufacturers that sales of ranitidine-based Zantac in the US would cease in April 2020 due to the potential for NDMA contamination. The amount of NDMA in a drug increases the longer it is kept on the market, but the FDA doesn’t know how long NDMA has been present in Zantac. Zantac 360, a new medication from Sanofi containing famotidine, is not included in the recalls or legal actions.
What’s After Being diagnosed with Cancer
Inform your doctor about your history with ranitidine if you received a cancer diagnosis after taking Zantac. They might use it to determine your diagnosis and suggested courses of treatment.
Keep any medical records and notes from your doctor. If the conditions are met, you might be eligible to file a Zantac lawsuit.
How do you know you qualify for the Zantac Lawsuit?
Zantac attorneys claim that in order to be eligible for legal action, a person must have a history of using Zantac, have been diagnosed with cancer, and have a link between their cancer diagnosis and Zantac. Only brand-name Zantac users can file cases, since generic ranitidine is no longer covered by this policy.
Only a lawyer can accurately assess a claim, and they may assist in compiling medical records and supporting evidence to strengthen a case.
Possible Health Issues in case you are diagnosed with Zantac Cancer
- Doctors run a test on people who have taken Zantac and are diagnosed with cancer to check if they have Crohn’s disease and primary pulmonary hypertension (PPH)
- A rare lung condition called primary pulmonary hypertension (PPH) raises the blood pressure in the lungs. The pulmonary artery’s pressure is increased above normal levels when the blood capillaries in the lungs narrow.
- Inflammatory bowel illness includes Crohn’s disease. Inflammation of the digestive tract brought on by it results in severe diarrhoea, cramps, stomach pain, and loss of weight.